SEC Form 4 · accession 0001782135-26-000033
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Johanna Mercier
Officer — Chief Comm & Corp Aff Officer
Period of report
Sep 15, 2026
Accepted (ET)
Sep 16, 2026 · 4:27 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 15, 2026 | S | 1,600 | $143.6917 | D | 118,084 | D | |
| Common StockF3 | Sep 15, 2026 | S | 800 | $144.4569 | D | 117,284 | D | |
| Common Stock | Sep 15, 2026 | S | 600 | $145.29 | D | 116,684 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
- F2Sale prices for the transactions reported range from $143.16 to $144.15. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
- F3Sale prices for the transactions reported range from $144.26 to $144.775. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.